Sign Up to like & get
recommendations!
0
Published in 2024 at "Journal of Dermatological Treatment"
DOI: 10.1080/09546634.2024.2324833
Abstract: Abstract Background Lebrikizumab, a high-affinity monoclonal antibody targeting IL-13, previously demonstrated clinical efficacy in three randomized, double-blind, placebo-controlled Phase 3 trials that included adults and adolescents with moderate-to-severe atopic dermatitis (AD): ADvocate1, ADvocate2, and ADhere.…
read more here.
Keywords:
moderate severe;
week;
adolescent patients;
three randomized ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "F1000Research"
DOI: 10.12688/f1000research.125861.1
Abstract: Background: Using the frequentist approach, a recent meta–analysis of three randomized clinical trials in patients undergoing intraoperative ventilation during general anesthesia for major surgery failed to show the benefit of ventilation that uses high positive…
read more here.
Keywords:
recruitment maneuvers;
analysis three;
ventilation;
analysis ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Diabetes care"
DOI: 10.2337/dc22-0888
Abstract: OBJECTIVE Sodium-glucose cotransporter 2 inhibitors (SGLT2i) and glucagon-like peptide 1 receptor agonists (GLP-1RA) reduce body weight and improve cardiometabolic health, but their effect on physical activity is unknown. RESEARCH DESIGN AND METHODS We pooled data…
read more here.
Keywords:
physical activity;
glucose lowering;
lowering therapies;
activity ... See more keywords